Inogen | INGN - Current Assets


Inogen reported $203.72M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 363.39M 17.86M Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Boston Scientific USD 8.16B 192M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dexcom USD 3.92B 170.6M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 2.04B 192.4M Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Orthofix International USD 446.13M 15.39M Jun/2026
Philips EUR 9.33B 454M Jun/2026
ResMed USD 3.51B 815.82M Sep/2026
Steris USD 2.48B 33.4M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teleflex USD 1.84B 31.2M Sep/2026
X T L Biopharmaceuticals USD 166K 367K Dec/2025
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026